Elixir Medical Announces Global Launch of LithiX HC-IVL System Following CE Mark Approval

Unique Design

The design of the LithiX HC - IVL system breaks through traditional thinking patterns, showcasing astonishing innovation. It adopts a semi - compliant balloon, which is like a carefully designed "elastic carrier". This balloon has a certain degree of flexibility, allowing it to better adapt to the complex physiological environment inside blood vessels, and also possesses appropriate support force to ensure stability and reliability during surgical operations. On the surface of the balloon, there are multiple low - profile metal hemispheres evenly distributed. These metal hemispheres are like "secret weapons" embedded on the balloon. Though seemingly small, they play a crucial role throughout the treatment process. This unique structure enables the perfect collaboration between the balloon and the metal hemispheres, laying a solid foundation for subsequent efficient treatment based on the Hertz contact stress principle. Compared with other similar products on the market, it demonstrates obvious differentiated advantages in both design concept and practical application effects.

Working Principle

The working principle of this system is based on the renowned Hertzian contact stress theory, which is ingeniously applied in the LithiX HC-IVL system, transforming into a powerful force for treating calcified arterial obstructions. During surgical treatment, the balloon is delivered to the calcified lesion site and begins inflating at low pressure. As the balloon gradually expands, the metallic hemispheres on its surface make close contact with the calcified plaque. Due to the unique shape and distribution of the metallic hemispheres, highly localized contact points are generated upon contact. These contact points act as tiny "pressure concentrators," efficiently amplifying the pressure exerted on the balloon. Under the influence of this locally amplified mechanical force, deep and extensive cracks form within the calcified plaque, successfully breaking down and fragmenting the previously hard-to-treat calcified tissue. More importantly, the entire process can be completed under low balloon inflation pressure, not only reducing the difficulty and risk of the procedure but also minimizing damage to surrounding non-calcified vascular tissues. This precision resembles that of a skilled craftsman meticulously sculpting the lesion without affecting the intact "artwork" around it, fully demonstrating the scientific and advanced nature of this working principle.

The Advantages Are Fully Displayed in Comparison

In the field of intravascular lithotripsy, numerous energy-based systems have emerged in an attempt to address the challenge of calcified arterial occlusions, but they face many challenges in practical applications. These energy-based systems often require additional equipment, such as complex energy-generating devices and precision control instruments. This not only increases procurement costs for medical institutions but also makes preoperative preparations cumbersome and complicated. For example, common intravascular lithotripsy systems based on shockwaves or laser energy need to be connected to large mainframe equipment during surgery. These mainframes are bulky, expensive, and impose high technical demands on both the operating environment and personnel. In practice, medical staff must spend significant time calibrating the equipment and ensuring the accuracy of energy parameters, making the entire workflow extremely complex. The slightest error could affect surgical outcomes and even pose risks to patients.

The LithiX HC-IVL system stands out among many competitors with its unique advantages, akin to a breath of fresh air. It is a balloon-based system with a design that is both simple and ingenious, cleverly integrating thin metal hemispheres onto the balloon while completely eliminating the need for additional equipment. This innovative design greatly simplifies the surgical operation process. When using the LithiX HC-IVL system, doctors can operate it just like a traditional balloon catheter—after delivering the balloon to the lesion site, they only need to inflate it at low pressure. The metal hemispheres on the balloon surface then automatically function based on the Hertzian contact stress principle. There is no need for complex equipment adjustments or concerns about incorrect energy parameter settings, significantly reducing preparation time and lowering the difficulty and risks of the procedure. For medical institutions, there is no need to invest heavily in additional equipment; purchasing the consumables of the LithiX HC-IVL system suffices, effectively reducing medical costs and improving resource utilization efficiency.

The LithiX HC-IVL System, with its innovative design, unique working principle, significant comparative advantages, and remarkable clinical outcomes, has demonstrated tremendous potential and value in the field of cardiovascular disease treatment. It provides doctors with a more efficient, safer, and more convenient therapeutic tool, enabling them to approach complex calcified arterial occlusive lesions with greater confidence and composure when formulating treatment plans, offering more hope to patients. For the vast number of patients suffering from calcified arterial occlusions, the LithiX HC-IVL System is undoubtedly a timely solution, bringing new hope for the improvement of their health and quality of life.

As the LithiX HC-IVL system is further promoted and applied in the global market, we have good reason to expect that it will play an even more significant role in the treatment of cardiovascular diseases. It has the potential to transform the current therapeutic landscape and become one of the standard treatments for calcified arterial blockages. At the same time, it is hoped that Elixir Medical Corporation will continue to increase its investment in research and development, constantly optimizing and improving the LithiX HC-IVL system. Further expanding its range of applications, enhancing treatment outcomes, and reducing treatment costs will allow more patients to benefit from it. Under the backdrop of continuous advancements in medical technology, innovative achievements like the LithiX HC-IVL system are expected to emerge like mushrooms after rain, providing more powerful tools to tackle cardiovascular diseases—a global health challenge—and enabling humanity to take even firmer steps on the path toward better health.

This Issue's Planning: Shen Li

Editorial Responsibility: Bao Lin Chen

Author of this article: Yun Ye Xuan

Post-production: Zhang Lirong